Listed by the USPTO as DELEO, VICTORIA LYNN
Tech Center 1600 • Art Units: 1662
This examiner grants 41% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19066527 | SOYBEAN VARIETY 5PBDP31 | Non-Final OA | PIONEER HI-BRED INTERNATIONAL, INC. |
| 18006423 | PLANT REGULATORY ELEMENTS AND METHODS OF USE THEREOF | Non-Final OA | PIONEER HI-BRED INTERNATIONAL, INC. |
| 18660692 | MERISTEM TRANSFORMATION METHOD USING A LIQUID SELECTION MEDIUM | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18015229 | PLANT METABOLITE-MEDIATED INDUCTION OF BIOFILM FORMATION IN SOIL BACTERIA TO INCREASE BIOLOGICAL NITROGEN FIXATION AND PLANT NITROGEN ASSIMILATION | Non-Final OA | The Regents of the University of California |
| 18560069 | SPINACH PLANT HAVING NOVEL DOWNY MILDEW-RESISTANT GENE | Non-Final OA | SAKATA SEED CORPORATION |
| 18722517 | POLLEN-MEDIATED FEED TRAIT DELIVERY IN HYBRID F2 PROGENY SEED | Final Rejection | INARI AGRICULTURE TECHNOLOGY, INC. |
| 19009709 | METHODS AND COMPOSITIONS FOR MODULATING TRICHOME DENSITY AND FLAVOR MOLECULE SECRETION | Non-Final OA | Altria Client Services LLC |
| 18876444 | RUST DISEASE RESISTANCE GENES AND USE THEREOF | Non-Final OA | Ramot at Tel-Aviv University Ltd. |
| 17919138 | METHODS FOR INDUCTION OF ENDOGENOUS TANDEM DUPLICATION EVENTS | Final Rejection | Academisch Ziekenhuis Leiden (h.o.d.n. LUMC) |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy41.4% of resolved applications examined by Victoria Lynn Deleo were allowed (29 resolved cases), compared with 63.0% across Art Unit 1662 over the last five years.
This examiner's interview lift is -44.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Victoria Lynn Deleo took 958 days on average from filing to allowance.
Victoria Lynn Deleo examines applications in Art Unit 1662 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
